Browse
We’re here to help

Find guidance on Author Services

Login | Register

Login
Register

Cart Add to Cart

Search
Browse
We’re here to help

Find guidance on Author Services

Home
All Journals
Lung Cancer: Targets and Therapy
List of Issues
Volume 10, Issue

Lung Cancer: Targets and Therapy

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

About this journalAbout

Current issue
All volumes & issues
Most read articles
Most cited articles

New content alerts
RSS

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Register a free Taylor & Francis Online account today to boost your research and gain these benefits:

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Register now or learn more

Cover image for Lung Cancer: Targets and Therapy, Volume 10, 2019

Lung Cancer: Targets and Therapy, Volume 10, Issue (2019)

Browse this journal

Current issue
List of issues
Most read articles
Most cited articles

Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Lung Cancer: Targets and Therapy, Volume 10, Issue (2019)

See all volumes and issues

Vol 15, 2024 Vol 14, 2023 Vol 13, 2022 Vol 12, 2021 Vol 11, 2020 Volume 10, 2019 Vol 9, 2018 Vol 8, 2017 Vol 7, 2016 Vol 6, 2015 Vol 5, 2014 Vol 4, 2013 Vol 3, 2012 Vol 2, 2011 Vol 1, 2010

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Original Research

Article

Outcome of uncommon EGFR mutation positive newly diagnosed advanced non-small cell lung cancer patients: a single center retrospective analysis

Shruti Kate, Anuradha Chougule, Amit Joshi, Vanita Noronha, Vijay Patil, Rohit Dusane, Leena Solanki, Priyanka Tiwrekar, Vaishakhi Trivedi & Kumar Prabhash

Pages: 1-10

Published online: 29 Jan 2019

AbstractforOutcome of uncommon EGFR mutation positive newly diagnosed advanced non-small cell lung cancer patients: a single center retrospective analysis | Full Text | References | PDF (678.1 KB) | EPUB

120 Views
13 CrossRef citations
0Altmetric

Open Access

Review

Review Article

Systematic review of sequencing of ALK inhibitors in ALK-positive non-small-cell lung cancer

Stephanie M Barrows, Kelly Wright, Catherine Copley-Merriman, James A Kaye, Marc Chioda, Robin Wiltshire, Knut Martin Torgersen & Elizabeth T Masters

Pages: 11-20

Published online: 21 Dec 2022

AbstractforSystematic review of sequencing of ALK inhibitors in ALK-positive non-small-cell lung cancer | Full Text | References | PDF (261.1 KB) | EPUB

146 Views
7 CrossRef citations
0Altmetric

Open Access

Case Report

Differential response to a combination of full-dose osimertinib and crizotinib in a patient with EGFR-mutant non-small cell lung cancer and emergent MET amplification

Viola W Zhu, Alexa B Schrock, Siraj M Ali & Sai-Hong Ignatius Ou

Pages: 21-26

Published online: 12 Mar 2019

AbstractforDifferential response to a combination of full-dose osimertinib and crizotinib in a patient with EGFR-mutant non-small cell lung cancer and emergent MET amplification | Full Text | References | PDF (3.1 MB) | EPUB

171 Views
13 CrossRef citations
0Altmetric

Open Access

Review

Review Article

Targeting RET-rearranged non-small-cell lung cancer: future prospects

Giuseppe Bronte, Paola Ulivi, Alberto Verlicchi, Paola Cravero, Angelo Delmonte & Lucio Crinò

Pages: 27-36

Published online: 21 Dec 2022

AbstractforTargeting RET-rearranged non-small-cell lung cancer: future prospects | Full Text | References | PDF (1.3 MB) | EPUB

284 Views
26 CrossRef citations
0Altmetric

Open Access

Review Article

Pain management in patients with malignant mesothelioma: challenges and solutions

J Saunders, M Ashton, C Hall, B Laird & N MacLeod

Pages: 37-46

Published online: 02 Apr 2019

AbstractforPain management in patients with malignant mesothelioma: challenges and solutions | Full Text | References | PDF (1.8 MB) | EPUB

190 Views
3 CrossRef citations
0Altmetric

Open Access

Article

Combination pembrolizumab plus chemotherapy: a new standard of care for patients with advanced non-small-cell lung cancer

Frank Weinberg & Shirish Gadgeel

Pages: 47-56

Published online: 04 Jun 2019

AbstractforCombination pembrolizumab plus chemotherapy: a new standard of care for patients with advanced non-small-cell lung cancer | Full Text | References | PDF (707.5 KB) | EPUB

189 Views
8 CrossRef citations
0Altmetric

Open Access

Original Research

Article

Impact of smoking on frequency and spectrum of K-RAS and EGFR mutations in treatment naive Indonesian lung cancer patients

Najmiatul Masykura, Jamal Zaini, Elisna Syahruddin, Sita Laksmi Andarini, Achmad Hudoyo, Refniwita Yasril, Asep Ridwanuloh, Heriawaty Hidajat, Fariz Nurwidya & Ahmad Utomo

Pages: 57-66

Published online: 16 Nov 2022

AbstractforImpact of smoking on frequency and spectrum of K-RAS and EGFR mutations in treatment naive Indonesian lung cancer patients | Full Text | References | PDF (325.1 KB) | EPUB

180 Views
3 CrossRef citations
0Altmetric

Open Access

Review

Article

Polo-like kinase 1 inhibition in NSCLC: mechanism of action and emerging predictive biomarkers

Jan A Stratmann & Martin Sebastian

Pages: 67-80

Published online: 16 Nov 2022

AbstractforPolo-like kinase 1 inhibition in NSCLC: mechanism of action and emerging predictive biomarkers | Full Text | References | PDF (690 KB) | EPUB

153 Views
4 CrossRef citations
0Altmetric

Open Access

Case Report

Article

TKI-resistant ALK-rearranged lung adenocarcinoma with secondary CTNNB1 p.S45V and tertiary ALK p.I1171N mutations

Madhu M Ouseph, Angela Taber, Humera Khurshid, Russell Madison, Bassam I Aswad, Murray B Resnick, Evgeny Yakirevich, Siraj M Ali & Nimesh R Patel

Pages: 81-86

Published online: 15 Aug 2019

AbstractforTKI-resistant ALK-rearranged lung adenocarcinoma with secondary CTNNB1 p.S45V and tertiary ALK p.I1171N mutations | Full Text | References | PDF (1.8 MB) | EPUB

91 Views
1 CrossRef citations
0Altmetric

Open Access

Review

Article

Profile of entrectinib and its potential in the treatment of ROS1-positive NSCLC: evidence to date

Francesco Facchinetti & Luc Friboulet

Pages: 87-94

Published online: 09 Sep 2019

AbstractforProfile of entrectinib and its potential in the treatment of ROS1-positive NSCLC: evidence to date | Full Text | References | PDF (516.6 KB) | EPUB

166 Views
10 CrossRef citations
0Altmetric

Open Access

Original Research

Article

A retrospective study evaluating the pretreatment tumor volume (PTV) in non-small cell lung cancer (NSCLC) as a predictor of response to program death-1 (PD-1) inhibitors

Misako Nagasaka, Nadine Abdallah, Marcus Crosby, Nithin Thummala, Dhaval Patel, Antoinette J Wozniak, Shirish Gadgeel, Judith Abrams & Ammar Sukari

Pages: 95-105

Published online: 12 Sep 2019

AbstractforA retrospective study evaluating the pretreatment tumor volume (PTV) in non-small cell lung cancer (NSCLC) as a predictor of response to program death-1 (PD-1) inhibitors | Full Text | References | PDF (2.2 MB) | EPUB

98 Views
1 CrossRef citations
0Altmetric

Open Access

Review

Review Article

Landscape on CT screening for lung cancer in Asia

Natthaya Triphuridet & Claudia Henschke

Pages: 107-124

Published online: 30 Sep 2019

AbstractforLandscape on CT screening for lung cancer in Asia | Full Text | References | PDF (1.9 MB) | EPUB

372 Views
6 CrossRef citations
0Altmetric

Open Access

Original Research

Article

Time To Response In Patients With Advanced Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small-Cell Lung Cancer (NSCLC) Receiving Alectinib In The Phase II NP28673 And NP28761 Studies

Shirish Gadgeel, Alice T Shaw, Fabrice Barlesi, Lucio Crino, James CH Yang, Anne-Marie Dingemans, Dong-Wan Kim, Filippo de Marinis, Mathias Schulz, Shiyao Liu, Ravindra Gupta, Vlatka Smoljanovic & Sai-Hong Ignatius Ou

Pages: 125-130

Published online: 13 Nov 2019

AbstractforTime To Response In Patients With Advanced Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small-Cell Lung Cancer (NSCLC) Receiving Alectinib In The Phase II NP28673 And NP28761 Studies | Full Text | References | PDF (3.3 MB) | EPUB

92 Views
2 CrossRef citations
0Altmetric

Open Access

Review

Review Article

Approaches to Tumor Classification in Pulmonary Sarcomatoid Carcinoma

Chiara Baldovini, Giulio Rossi & Alessia Ciarrocchi

Pages: 131-149

Published online: 16 Nov 2022

AbstractforApproaches to Tumor Classification in Pulmonary Sarcomatoid Carcinoma | Full Text | References | PDF (4.4 MB) | EPUB

312 Views
14 CrossRef citations
0Altmetric

Open Access

Original Research

Article

Outcomes Following Stereotactic Body Radiotherapy with Intensity-Modulated Therapy versus Three-Dimensional Conformal Radiotherapy in Early Stage Non-Small Cell Lung Cancer

Michael Mix, Sean Tanny, Tamara Nsouli, Ryan Alden, Rishabh Chaudhari, Russell Kincaid, Paula F Rosenbaum, Jeffrey A Bogart & Paul Aridgides

Pages: 151-159

Published online: 20 Dec 2019

AbstractforOutcomes Following Stereotactic Body Radiotherapy with Intensity-Modulated Therapy versus Three-Dimensional Conformal Radiotherapy in Early Stage Non-Small Cell Lung Cancer | Full Text | References | PDF (4.1 MB) | EPUB

105 Views
1 CrossRef citations
0Altmetric

Open Access

Review

Review Article

Immune Checkpoint Inhibitors for the Treatment of Unresectable Stage III Non–Small Cell Lung Cancer: Emerging Mechanisms and Perspectives

Hiroyuki Inoue & Isamu Okamoto

Pages: 161-170

Published online: 03 Jan 2020

AbstractforImmune Checkpoint Inhibitors for the Treatment of Unresectable Stage III Non–Small Cell Lung Cancer: Emerging Mechanisms and Perspectives | Full Text | References | PDF (5.2 MB) | EPUB

122 Views
4 CrossRef citations
0Altmetric

Open Access

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Spotlight on Patritumab Deruxtecan (HER3-DXd) from HERTHENA Lung01. Is a Median PFS of 5.5 Months Enough in Light of FLAURA-2 and MARIPOSA?

Zhaohui Liao Arter et al.

Article Commentary | Published online: 9 Jul 2024

Open Access

Top 20 EGFR+ NSCLC Clinical and Translational Science Papers That Shaped the 20 Years Since the Discovery of Activating EGFR Mutations in NSCLC. An Editor-in-Chief Expert Panel Consensus Survey.

Sai-Hong Ignatius Ou et al.

Article | Published online: 21 Jun 2024

Open Access

ATTLAS, IMpower151 and ORIENT-31: Dusting off IMpower150 for Post-Osimertinib in EGFR-Mutated NSCLC?

Jii Bum Lee et al.

Article Commentary | Published online: 24 May 2024

Open Access

LIBRETTO-431: Confirming the Superiority of Selpercatinib to Chemotherapy and the Lack of Efficacy of Immune Checkpoint Inhibitors in Advanced RET Fusion-Positive (RET+) NSCLC, Another Unique Never-Smoker Predominant Molecular Subtype of NSCLC

Alexandria TM Lee et al.

Article Commentary | Published online: 23 May 2024

Open Access

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Lung Cancer: Targets and Therapy (Vol.10, Iss., 2019)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?